All Cosmos Bio-Tech Holding Corp (4148) - Net Assets

Latest as of December 2025: NT$3.44 Billion TWD ≈ $108.53 Million USD

Based on the latest financial reports, All Cosmos Bio-Tech Holding Corp (4148) has net assets worth NT$3.44 Billion TWD (≈ $108.53 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$4.22 Billion ≈ $133.10 Million USD) and total liabilities (NT$779.83 Million ≈ $24.57 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check All Cosmos Bio-Tech Holding Corp tangible equity quality to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	NT$3.44 Billion
% of Total Assets	81.54%
Annual Growth Rate	11.02%
5-Year Change	44.83%
10-Year Change	121.17%
Growth Volatility	15.03

All Cosmos Bio-Tech Holding Corp - Net Assets Trend (2010–2025)

This chart illustrates how All Cosmos Bio-Tech Holding Corp's net assets have evolved over time, based on quarterly financial data. See 4148 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for All Cosmos Bio-Tech Holding Corp (2010–2025)

The table below shows the annual net assets of All Cosmos Bio-Tech Holding Corp from 2010 to 2025. For live valuation and market cap data, see how much is All Cosmos Bio-Tech Holding Corp worth.

Year	Net Assets	Change
2025-12-31	NT$3.44 Billion ≈ $108.53 Million	+10.05%
2024-12-31	NT$3.13 Billion ≈ $98.62 Million	+11.23%
2023-12-31	NT$2.81 Billion ≈ $88.66 Million	-1.71%
2022-12-31	NT$2.86 Billion ≈ $90.21 Million	+20.37%
2021-12-31	NT$2.38 Billion ≈ $74.94 Million	+0.65%
2020-12-31	NT$2.36 Billion ≈ $74.45 Million	-2.59%
2019-12-31	NT$2.43 Billion ≈ $76.43 Million	-4.34%
2018-12-31	NT$2.54 Billion ≈ $79.90 Million	+8.13%
2017-12-31	NT$2.35 Billion ≈ $73.89 Million	+50.57%
2016-12-31	NT$1.56 Billion ≈ $49.07 Million	+9.24%
2015-12-31	NT$1.43 Billion ≈ $44.92 Million	+1.47%
2014-12-31	NT$1.41 Billion ≈ $44.27 Million	+21.39%
2013-12-31	NT$1.16 Billion ≈ $36.47 Million	-2.83%
2012-12-31	NT$1.19 Billion ≈ $37.53 Million	+31.93%
2011-12-31	NT$903.04 Million ≈ $28.45 Million	+25.73%
2010-12-31	NT$718.24 Million ≈ $22.63 Million	--

Equity Component Analysis

This analysis shows how different components contribute to All Cosmos Bio-Tech Holding Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 1119.3% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	NT$923.39 Million	33.66%
Common Stock	NT$672.36 Million	24.51%
Other Comprehensive Income	NT$371.37 Million	13.54%
Other Components	NT$775.96 Million	28.29%
Total Equity	NT$2.74 Billion	100.00%

All Cosmos Bio-Tech Holding Corp Competitors by Market Cap

The table below lists competitors of All Cosmos Bio-Tech Holding Corp ranked by their market capitalization.

Company	Market Cap
GBM Resources Limited AU:GBM	$65.99 Million
Ariadne Australia Ltd AU:ARA	$66.00 Million
Cape EMS Berhad KLSE:5311	$66.00 Million
Principal Real Estate Income Closed Fund NYSE:PGZ	$66.07 Million
Careium AB ST:CARE	$65.97 Million
Symphony Communication Public Company Limited BK:SYMC	$65.96 Million
Premier Polyfilm Limited NSE:PREMIERPOL	$65.94 Million
China Fangda Group Co Ltd SHE:200055	$65.91 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in All Cosmos Bio-Tech Holding Corp's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 2,515,235,000 to 2,743,086,000, a change of 227,851,000 (9.1%).
Net income of 152,999,000 contributed positively to equity growth.
Dividend payments of 32,017,000 reduced retained earnings.
Other comprehensive income increased equity by 371,374,000.
Other factors decreased equity by 264,505,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	NT$153.00 Million	+5.58%
Dividends Paid	NT$32.02 Million	-1.17%
Other Comprehensive Income	NT$371.37 Million	+13.54%
Other Changes	NT$-264.50 Million	-9.64%
Total Change	NT$-	9.06%

Book Value vs Market Value Analysis

This analysis compares All Cosmos Bio-Tech Holding Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.03x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 1.87x to 1.03x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2011-12-31	NT$16.70	NT$31.15	x
2012-12-31	NT$20.92	NT$31.15	x
2013-12-31	NT$20.82	NT$31.15	x
2014-12-31	NT$24.72	NT$31.15	x
2015-12-31	NT$21.81	NT$31.15	x
2016-12-31	NT$23.29	NT$31.15	x
2017-12-31	NT$33.45	NT$31.15	x
2018-12-31	NT$33.82	NT$31.15	x
2019-12-31	NT$31.91	NT$31.15	x
2020-12-31	NT$30.98	NT$31.15	x
2021-12-31	NT$31.00	NT$31.15	x
2022-12-31	NT$35.84	NT$31.15	x
2023-12-31	NT$31.86	NT$31.15	x
2024-12-31	NT$38.88	NT$31.15	x
2025-12-31	NT$30.33	NT$31.15	x

Capital Efficiency Dashboard

This dashboard shows how efficiently All Cosmos Bio-Tech Holding Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 5.58%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 5.19%
• Asset Turnover: 0.70x
• Equity Multiplier: 1.54x
Recent ROE (5.58%) is below the historical average (12.16%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2011	19.46%	11.56%	1.07x	1.58x	NT$78.92 Million
2012	20.13%	11.66%	0.98x	1.76x	NT$105.85 Million
2013	15.23%	8.45%	0.96x	1.87x	NT$54.41 Million
2014	15.21%	8.77%	0.94x	1.84x	NT$67.00 Million
2015	15.96%	8.73%	0.96x	1.90x	NT$73.60 Million
2016	18.25%	11.77%	0.98x	1.59x	NT$109.93 Million
2017	15.84%	14.26%	0.84x	1.32x	NT$118.98 Million
2018	14.04%	11.35%	0.90x	1.37x	NT$87.82 Million
2019	1.74%	2.02%	0.67x	1.29x	NT$-168.88 Million
2020	4.14%	5.00%	0.63x	1.32x	NT$-116.45 Million
2021	9.95%	9.02%	0.74x	1.49x	NT$-908.60K
2022	15.56%	9.95%	0.90x	1.74x	NT$131.51 Million
2023	6.18%	4.93%	0.77x	1.63x	NT$-86.07 Million
2024	5.11%	5.23%	0.67x	1.46x	NT$-122.94 Million
2025	5.58%	5.19%	0.70x	1.54x	NT$-121.31 Million

Industry Comparison

This section compares All Cosmos Bio-Tech Holding Corp's net assets metrics with peer companies in the Agricultural Inputs industry.

Industry Context

Industry: Agricultural Inputs
Average net assets among peers: $12,142,792,667
Average return on equity (ROE) among peers: 3.19%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
All Cosmos Bio-Tech Holding Corp (4148)	NT$3.44 Billion	19.46%	0.23x	$65.99 Million
Sinon Corp (1712)	$4.45 Billion	5.79%	0.75x	$525.28 Million
Taiwan Fertilizer Co Ltd (1722)	$29.53 Billion	0.00%	0.66x	$1.51 Billion
Huikwang (6508)	$2.45 Billion	3.78%	0.18x	$64.75 Million

About All Cosmos Bio-Tech Holding Corp

TW:4148 Taiwan Agricultural Inputs

Market Cap

$65.99 Million

NT$2.09 Billion TWD

Market Cap Rank

#20898 Global

#1279 in Taiwan

Share Price

NT$31.15

Change (1 day)

+2.81%

52-Week Range

NT$30.30 - NT$46.30

All Time High

NT$126.05